Early Lyophilised plasma In Patients with haemorrhagic Shock (ELIPS-Trial)

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-523151-66-00

Enrollment

Registered

2026-01-26

Start date

Unknown

Completion date

Unknown

Last updated

2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Haemorrhagic shock

Brief summary

Interventions

DRUGELO-MEL isoton - Infusionslösung

DRUGLyoPlas N - W

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Design outcomes

Primary

Measure	Time frame
NA	—

Countries

Austria

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026